Human CCL11/MGC22554 ORF/cDNA clone-Adenovirus particle (BC017850)
Cat. No.: vGMAP000414
Pre-made Human CCL11/MGC22554 Adenovirus for CCL11 overexpression in-vitro and in-vivo. The CCL11 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified CCL11-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.
At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.
Go to
CCL11/Eotaxin/CCL11/MGC22554 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Adenovirus Grade | Adenovirus quantity |
| vGMAP000414 | Human CCL11 Adenovirus particle | Research Grade-In vitro | 1E+10PFU (1E+10pfu/ml×1ml) |
| 5E+10PFU (1E+10pfu/ml×5ml) | |||
| 1E+11PFU (1E+10pfu/ml×10ml) | |||
| Research Grade-In vivo | 1E+11PFU (1E+11pfu/ml×1ml) | ||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAP000414 |
| Gene Name | CCL11 |
| Accession Number | BC017850 |
| Gene ID | 6356 |
| Species | Human |
| Product Type | Adenovirus particle (overexpression) |
| Insert Length | 294 bp |
| Gene Alias | MGC22554 |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAAGGTCTCCGCAGCACTTCTGTGGCTGCTGCTCATAGCAGCTGCCTTCAGCCCCCAGGGGCTCGCTGGGCCAGCTTCTGTCCCAACCACCTGCTGCTTTAACCTGGCCAATAGGAAGATACCCCTTCAGCGACTAGAGAGCTACAGGAGAATCACCAGTGGCAAATGTCCCCAGAAAGCTGTGATCTTCAAGACCAAACTGGCCAAGGATATCTGTGCCGACCCCAAGAAGAAGTGGGTGCAGGATTCCATGAAGTATCTGGACCAAAAATCTCCAACTCCAAAGCCATAA |
| ORF Protein Sequence | MKVSAALLWLLLIAAAFSPQGLAGPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKWVQDSMKYLDQKSPTPKP |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-INN-755 | Pre-Made Bertilimumab Biosimilar, Whole Mab, Anti-Ccl11 Antibody: Anti-SCYA11 therapeutic antibody |
| Target Antibody | GM-Tg-g-T16888-Ab | Anti-CCL11/ SCYA11 functional antibody |
| Target Antigen | GM-Tg-g-T16888-Ag | CCL11 protein |
| Cytokine | cks-Tg-g-GM-T16888 | chemokine (C-C motif) ligand 11 (CCL11) protein & antibody |
| ORF Viral Vector | pGMLP000540 | Human CCL11 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000414 | Human CCL11 Adenovirus plasmid |
| ORF Viral Vector | vGMLP000540 | Human CCL11 Lentivirus particle |
| ORF Viral Vector | vGMAP000414 | Human CCL11 Adenovirus particle |
Target information
| Target ID | GM-T16888 |
| Target Name | CCL11/Eotaxin |
|
Gene Group Identifier (Target Gene ID in Homo species) |
6356 |
| Gene ID | 574218 (Macaca mulatta), 6356 (Homo sapiens) |
| Gene Symbols & Synonyms | CCL11,SCYA11,Eotaxin |
| Target Alternative Names | C-C motif chemokine 11,CCL11,Eosinophil chemotactic protein,Eotaxin,SCYA11,Small-inducible cytokine A11 |
| Uniprot Accession |
P51671,Q8MIT7
Additional SwissProt Accessions: Q8MIT7,P51671 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, INN Index, Cytokine Target |
| Disease | Ovary Cancer |
| Disease from KEGG | Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Chemokine signaling pathway, IL-17 signaling pathway, Asthma |
| Gene Ensembl | ENSMMUG00000064793, ENSG00000172156 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


